enVVeno Medical (NVNO) Change in Account Payables (2017 - 2023)
enVVeno Medical's (NVNO) quarterly Change in Account Payables came in at $924000.0 in Q2 2023, up 93.71% year-on-year from $477000.0 in Q2 2022, and up 444.78% quarter-over-quarter from -$268000.0 in Q1 2023.
enVVeno Medical (NVNO) Change in Account Payables (2017 - 2023) Analysis & Trends
enVVeno Medical's Change in Account Payables history runs 7 years deep, the most recent figure standing at $924000.0 for Q2 2023.
- On a quarterly basis, Change in Account Payables rose 93.71% year-over-year to $924000.0 in Q2 2023; TTM through Jun 2023 was $270000.0, a 62.76% decrease from a year earlier, with the FY2023 full-year figure at -$221000.0, down 351.14% from the prior year.
- Change in Account Payables grew to $924000.0 in Q2 2023 per NVNO's latest filing, from -$268000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $924000.0 in Q2 2023 and bottomed at -$681000.0 in Q1 2021.
- The 5-year median for Change in Account Payables is $52372.0 (2019), against an average of $12457.8.
- Across the five-year window, Change in Account Payables surged 4119.56% in 2020 and plunged 8833.33% in 2023, its largest moves.
- Year by year, Change in Account Payables stood at $9862.0 in 2019, then jumped by 4119.56% to $416133.0 in 2020, then plunged by 60.35% to $165000.0 in 2021, then dropped by 10.91% to $147000.0 in 2022, then soared by 528.57% to $924000.0 in 2023.
- Per Business Quant, the three latest NVNO Change in Account Payables figures stand at $924000.0 (Q2 2023), -$268000.0 (Q1 2023), and $147000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 924,000.00 |
| Mar 31, 2023 | -268,000.00 |
| Mar 31, 2023 | -268,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | -533,000.00 |
| Sep 30, 2022 | -533,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 165,000.00 |
| Dec 31, 2021 | 165,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | -403,000.00 |
| Jun 30, 2021 | -403,000.00 |
| Mar 31, 2021 | -681,000.00 |
| Mar 31, 2021 | -681,000.00 |